Navigation Links
Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing
Date:7/29/2010

TOKYO, July 29 /PRNewswire/ -- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™ MF-SL filters enable biopharmaceutical manufacturers to improve the efficiency and effectiveness of their protein harvest step.

Developed using Asahi Kasei's unique technology base in hollow-fiber filtration and polymer science, BioOptimal™ MF-SL filters offer superior filtration performance that results in faster processing times and higher-quality protein streams, even when filtering high-density cell culture solutions. The unique hollow-fiber membrane structure used in BioOptimal™ MF-SL filters enables gentle processing of cells and proteins in tangential flow mode, which reduces the burden on subsequent processing steps, and additionally makes BioOptimal™ MF-SL filters suitable for use in perfusion-based fermentation processes.

The key features of BioOptimal™ MF-SL are as follows:

  1. High throughput and fast processing times.
  2. Excellent filter performance even with high-density cell culture.
  3. High clarity of filtrate, even with highly turbid cell culture.
  4. Availability of various surface area sizes, making for easy scalability.
  5. Chemically stable polysulfone membrane, compatible with industry standard cleaning and sterilization processes.

About Asahi Kasei Medical

As a part of the Asahi Kasei Group's sharpening focus on healthcare-related fields, Asahi Kasei Medical is steadily developing its range of advanced manufacturing solutions for the bioprocess industry. The company is the established global market leader in virus filtration products, with its Planova™ virus removal filters having an unrivalled 20 year history of trusted use in the production of biotherapeutics. An innovative line-up of equipment solutions for bioprocessing—including chromatography equipment, in-line buffer dilution systems, and virus filtration and integrity test skids—are also available from its wholly owned US subsidiary Asahi Kasei Bioprocess, Inc. The launch of BioOptimal™ MF-SL filters marks a notable addition to Asahi Kasei Medical's range of unique products that continue to provide heightened reliability and efficiency in bioprocessing.


'/>"/>
SOURCE Asahi Kasei Medical Co., Ltd., Planova Division
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com
2. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
3. Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1%
4. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
5. MAQUET Cardiovascular Launches Advanced VASOVIEW Technology for Endoscopic Vessel Harvesting Procedures in Cardiac Surgery
6. Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches
7. Mylan Launches the Generic Version of Solodyn®, 45 mg, 90 mg and 135 mg Tablets, Announces Settlement Agreement with Medicis
8. Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA
9. Dynatronics Launches E-Commerce Website
10. Concert Medical Launches Conductor™ Family of Interventional Coronary Guidewires
11. In the Face of Pain® Launches New Facebook Community for Pain Management Advocates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... 2017  Cellect Biotechnology Ltd. (NASDAQ: APOP ... the functional selection of stem cells, today provided a ... quarter ended March 31 st , 2017. ... the first quarter of 2017," said Dr. Shai Yarkoni, ... the treatment of the first blood cancer patient in ...
(Date:5/24/2017)... 24, 2017  ivWatch LLC today announced the ... Board to enable seamless integration of ivWatch,s groundbreaking ... infusion pumps and other devices. By integrating ivWatch ... to help health care customers deliver a higher ... to IV therapy. "The ivWatch OEM ...
(Date:5/22/2017)... , May 22, 2017  As the ... a whole continue to make the revolutionary shift ... increasingly important for ensuring positive patient outcomes and ... stakeholders are shifting focus away from clinical trials ... effects of long-term specialty drug therapy utilization in ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is ... Top Doctor for 2017. Each year, research and information firm, Castle Connolly, releases their ... title in 2015, this marks the 3rd time that Dr. Canales has ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... grant from the American Heart Association (AHA) to launch a Rheumatic Heart Disease ... the prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged ...
(Date:6/22/2017)... ... June 22, 2017 , ... Vighter, a premier ... received certification for ANSI/ASIS PSC.1-2012. The company’s work in countries throughout Southwest Asia, ... of law has been degraded. The PSC.1 standard was created to protect fundamental ...
(Date:6/20/2017)... Tennessee (PRWEB) , ... June 20, 2017 , ... ... care services, announced today that Claritas Capital, a Nashville-based private equity firm, has ... accelerate our expansion plans for some time, and Claritas Capital offers the smart ...
(Date:6/20/2017)... ... 2017 , ... After months of negotiations, FaceCradle USA is proud to announce the debut of ... , “Introducing our product on QVC is something we all worked hard to achieve for ... more than 90 million homes in the United States,” said FaceCradle USA President Dylan Doherty. ...
Breaking Medicine News(10 mins):